Table 2.

Observed and relative survival after 1, 3, and 5 years of diagnosis of oropharynx cancer.

Survival	Observed						Relative
	1 year		3 years		5 years		1 year		3 years		5 years
	%	CI 95%	%	CI 95%	%	CI 95%	%	CI 95%	%	CI 95%	%	CI 95%
Sex
Men	61	55.9–66.0	37.5	32.2–42.7	31.5	26.6–36.4	61.9	56.8–67.5	39.2	34.1–45.0	34.2	29.2–40.1
Women	63.8	50.2–77.3	57.4	43.2–71.5	51.1	36.8–65.4	64.3	51.9–79.8	58.6	45.8–75.0	53.3	40.3–70.5
Total	61.3	56.4–66.2	40	35.1–44.9	33.9	29.2–38.6	62.2	57.4–67.4	41.6	36.8–47.1	36.6	31.8–42.1
Age
40–64	64.1	58.4–69.7	40.5	34.6–46.3	34.4	28.7–40.0	64.6	59.0–70.8	41.4	35.8–48.0	36	30.5–42.6
65+	50	40.4–59.6	36.5	27.2–45.7	29.8	20.9–38.6	52	42.9–63.0	40.8	31.7–52.5	37.1	27.6–49.8
Location
Base of tongue	58	50.0–66.0	31.5	23.8–39.1	28	20.5–35.4	59.1	51.4–67.9	33.2	26.1–42.3	31.2	24.0–40.6
Tonsil	67.2	58.7–75.6	46.2	37.1–55.2	40.3	31.5–49.1	63.1	54.9–72.6	48	39.6–58.3	43.5	35.0–54.1
Soft palate	70.6	55.3–85.8	47.1	30.2–63.9	32.4	16.7–48.1	68.9	54.6–86.9	49.1	34.4–70.2	34.4	21.2–56.0
Oropharynx	64.3	54.1–74.4	44	33.4–54.6	35.7	25.5–45.9	64.1	54.4–75.5	44.5	34.8–57.0	38.3	28.8–51.0
Period
1978–1986	60	50.4–69.6	48	38.2–57.8	42	32.4–51.6	61.1	52.0–71.7	50.1	40.9–61.5	45.6	36.2–57.4
1987–1994	62.9	54.8–70.9	32.4	24.5–40.2	28.1	20.6–35.5	60.6	52.9–69.5	33.8	26.6–42.9	30.4	23.3–39.6
1995–2002	65.2	57.3–73.0	41.8	33.5–50.0	34	26.1–41.8	64.6	57.0–73.1	43.3	35.6–52.6	36.5	29.0–45.9